QCBio Research Seminar: Zhiqian Zhai (Li JJ), Graduate Student in Statistics

Boyer Hall 159

TITLE: "Supervised capacity preserving mapping: a clustering guided visualization method for scRNA-seq data." ABSTRACT: Recently, various computational methods have been developed to analyze the scRNAseq data, such as clustering and visualization. However, current visualization methods, including t-SNE and UMAP, are challenged by the limited accuracy of rendering the geometric relationship of populations with distinct functional […]

QCBio Research Seminar: Friedrich Simmel, Department of Bioscience, School of Natural Sciences, TU Munich, Germany

Boyer 159 611 Charles E. Young Dr. E., Los Angeles, CA, United States

TITLE: "Electric actuation of DNA-based molecular machines.” ABSTRACT: A wide range of machine-like molecular assemblies have been generated over the past years. Most of them have been driven (or controlled) by DNA hybridization, utilization of buffer changes, or using chemical modifications such as photoswitches. A more recently explored strategy is the use of electrical fields for the manipulation of DNA devices, which enables fast […]

QCBio/Center for Biological Physics: Gregoire Altan-Bonnet, Principal Investigator – Immunodynamics group Laboratory of Integrative Cancer Immunology NCI, NIH, Bethesda MD

Boyer Hall 130

TITLE: “Stochasticity in cancer immunotherapies: identifying the T cell subset that sparks tumor eradication” ABSTRACT: We use an ex vivo model of tumor eradication to dissect the fundamental variability of clinical outcomes in cancer immunotherapies. We demonstrate that there exists an inherent stochastic variability in immune responses, based on the low abundance of hyper-responsive naïve T cells (so-called […]

QCBio Research Seminar: Gregoire Altan-Bonnet, Principal Investigator – Immunodynamics group Laboratory of Integrative Cancer Immunology NCI, NIH, Bethesda MD

Boyer 159

TITLE: "Stochasticity in cancer immunotherapies: identifying the T cell subset that sparks tumor eradication" ABSTRACT: We use an ex vivo model of tumor eradication to dissect the fundamental variability of clinical outcomes in cancer immunotherapies. We demonstrate that there exists an inherent stochastic variability in immune responses, based on the low abundance of hyper-responsive naïve T cells (so-called Spark T cells) and feedback regulations […]